stars 1 stars 2 stars 3

BioIntelligence Technologies inc. design and commercialize intelligent monitoring instruments with embedded analytic package to accelerate bioprocess development and maximize production profitability. Our instruments perform real-time analysis as well as prediction over time of both biologic variables and financial indicators. Among the benefits of using these products, users can: *increase revenues by taking early decisions and actions based on predicted final product yields; *reduce costs by quickly identifying non-profitable operations and non-profitable batches; *save time using personalized dashboards and the real-time automatic reporting modules. Our clients are biopharmaceutics, biocosmetics, food and supplement companies, environmental process users, bioprocess development centers, research & scale-up groups as well as academic groups. Real-time knowledge of how kinetics, actions and recipe affect revenues and costs makes the ROI of such real-time intelligent monitoring system very fast and lucrative. Go to biointelligence.com to see our products proudly made for bio people.

BioIntelligence Technologies Inc. Questions

The BioIntelligence Technologies Inc. annual revenue was $6.1 million in 2026.

Joel Sirois is the President and CEO of BioIntelligence Technologies Inc..

13 people are employed at BioIntelligence Technologies Inc..

BioIntelligence Technologies Inc. is based in Sherbrooke, Quebec.

The NAICS codes for BioIntelligence Technologies Inc. are [54171, 541, 54, 541713, 5417].

The SIC codes for BioIntelligence Technologies Inc. are [87, 873].

Top BioIntelligence Technologies Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users